Investor Relations

Latest News

Aug 16, 2019

MPX International Announces Closing of Acquisition of Gmp-Ready Pharmaceutical Facility in Malta

View Press Release

Aug 6, 2019

MPX International Adds New Senior Management to Support International Growth

Jul 31, 2019

MPX International Featured in a BBC Documentary on Canadian Cannabis Policy

View All News

Investor Presentation

View Presentation

Corporate Update

Jun 26, 2019 • 7:00 am EDT

View Event View All

Company Overview

MPX International Corporation is focused on developing and operating assets across the global cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient.

View Management Team View Board of Directors

Investor Contact Information

Company

MPX International Corporation
5255 Yonge Street
Suite 701
Toronto, ON M2N 6P4
Canada
T: 416-840-3725
info@mpxinternationalcorp.com